Evidence map›Paper›PMID 26853601›Full record

Trial reportEuropean journal of nutrition2017

A khorasan wheat-based replacement diet improves risk profile of patients with type 2 diabetes mellitus (T2DM): a randomized crossover trial.

Anne Whittaker, Monica Dinu, Francesca Cesari, Anna Maria Gori, Claudia Fiorillo, Matteo Becatti, Alessandro Casini, Rossella Marcucci, Stefano Benedettelli, Francesco Sofi

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of nutrition, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 2 pooled it
9.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 2 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Anne WhittakerDepartment of Agrifood Production and Environmental Sciences, University of Florence, Florence, Italy.
Monica DinuDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy. monicadinu89@gmail.com.
Francesca CesariUnit of Atherothrombotic Diseases, Careggi University Hospital, Florence, Italy.
Anna Maria GoriDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Claudia FiorilloDepartment of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy.
Matteo BecattiDepartment of Clinical and Experimental Biomedical Sciences, University of Florence, Florence, Italy.
Alessandro CasiniDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Rossella MarcucciDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Stefano BenedettelliDepartment of Agrifood Production and Environmental Sciences, University of Florence, Florence, Italy.
Francesco SofiDepartment of Experimental and Clinical Medicine, University of Florence, Florence, Italy.
Azienda Ospedaliero-Universitaria Careggi · ITUniversity of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposesThe aim of the present study was to examine whether a replacement diet with products made with organic ancient khorasan wheat could provide additive protective effects in reducing glucose, insulin, lipid and inflammatory risk factors, and in restoring blood redox balance in type 2 diabetes mellitus (T2DM) patients compared to diet with product made with modern organic wheat.

methodsWe conducted a randomized, double-blinded crossover trial with two intervention phases on 21 T2DM patients (14 females, 7 males). The participants were assigned to consume products (bread, pasta, crackers and biscuits) made using semi-whole flour from organic wheat that was either from ancient khorasan wheat or modern control wheat for 8 weeks in a random order. An 8-week washout period was implemented between the interventions. Laboratory analyses were performed both at the beginning and at the end of each intervention phase.

resultsThe metabolic risk profile improved only after the khorasan intervention period, as measured by a reduction in total and LDL cholesterol (mean reduction: -3.7 and -3.4 %, respectively), insulin (-16.3 %) and blood glucose (-9.1 %). Similarly, there was a significant reduction in circulating levels of reactive oxygen species (ROS), vascular endothelial growth factor (VEGF) and interleukin-1ra, and a significant increase of total antioxidant capacity (+6.3 %). No significant differences from baseline were noted after the modern control wheat intervention phase. The change (from pre- to post-intervention) between the two intervention arms was significantly different (p < 0.05) for total and LDL-c, insulin and HOMA index.

conclusionsA replacement diet with ancient khorasan wheat consumption provided additive protection in reducing total and LDL cholesterol, insulin, blood glucose, ROS production, and some inflammatory risk factors, which are all key factors warranting of control in secondary prevention of T2DM compared to a diet with products made with modern wheat.

Indexed as

DietAgedBlood GlucoseBody Mass IndexCholesterol, LDLCross-Over StudiesDiabetes Mellitus, Type 2Double-Blind MethodFemaleFlourHumansInsulinIranLife StyleMaleMiddle AgedBlood GlucoseCholesterol, LDLInsulinReactive Oxygen SpeciesVascular Endothelial Growth Factor AAncient wheatGlycaemiaInflammation cytokinesKhorasan wheatModern wheatOrganic wheatOxidative stressSecondary preventionType 2 diabetes mellitus

Identifiers

PMID26853601
PMCPMC5346426
OpenAlexW2265677789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.